RNA interference (RNAi) therapy offers groundbreaking potential to revolutionize disease treatment by targeting gene silencing. Opportunities lie in developing alternative treatments for conditions ...

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "RNA Interference Market by Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering. The global RNA ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "RNA Interference Market by Type, by Application, by End-user, and by Region" report has been added to ...

NEW YORK - Silexion Therapeutics Corp. (NASDAQ:SLXN), a micro-cap biotech company with a market capitalization of $6.33 million, announced new preclinical data showing its RNA interference therapy ...

Techniques such as RNA interference (RNAi), RNA editing, and the CRISPR/Cas system are being explored to target specific RBPs and circRNAs. By disrupting harmful circRNA-RBP interactions or enhancing ...

NEW DELHI: With Chikungunya continuing to leave thousands of Indians with prolonged and debilitating joint pain, the Indian Council of Medical Research (ICMR) has moved to fast-track a potential ...

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the RNA Therapy Clinical Trials sector include an increase in chronic and rare diseases, advancements in delivery technologies like lipid ...